Stocks Screener

Specify Company / Ticker to Get the Summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Guardant Health Inc

GH
Current price
48.30 USD +0.89 USD (+1.88%)
Last closed 45.64 USD
ISIN US40131M1099
Sector Healthcare
Industry Diagnostics & Research
Exchange NASDAQ
Capitalization 5 851 389 440 USD
Yield for 12 month +165.53 %
1Y
3Y
5Y
10Y
15Y
GH
21.11.2021 - 28.11.2021

Guardant Health, Inc., a precision oncology company, provides blood and tissue tests, and data sets in the United States and internationally. The company provides precision oncology testing services comprising Guardant360, a panel of genetic tests; Guardant360 LDT that measures 730+ genes and supports all guideline-recommended biomarkers; Guardant360 CDx Test, a liquid biopsy test; Guardant360 Response Test, a blood-only liquid biopsy; Guardant360 TissueNext Test, a tissue-based test with AI-powered PD-L1 detection; GuardantINFINITY Test that provides insights into the complexities of tumor molecular profiles and immune response to advance cancer research and therapy development; GuardantConnect, an integrated software-based solution designed for clinical and biopharmaceutical customers to connect patients tested with assays with actionable alterations with potentially relevant clinical studies; GuardantOMNI blood test for advanced stage cancer; and GuardantINFORM, an in-silico research platform for tumor evolution and treatment resistance across various biomarker-driven cancers. It also offers Shield Test; Guardant Reveal Test for adjuvant treatment and surveillance settings in early-stage cancer patients; and Smart Liquid Biopsy Platform. In addition, the company provides development services, including companion diagnostic development and regulatory approval, clinical study setup, monitoring and maintenance, testing development and support, technologies licensing, and kit fulfillment and delivery of Shield screening tests. The company was incorporated in 2011 and is headquartered in Palo Alto, California. Address: 3100 Hanover Street, Palo Alto, CA, United States, 94304

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

56.24 USD

P/E ratio

Dividend Yield

Current Year

+739 016 000 USD

Last Year

+563 948 000 USD

Current Quarter

+201 814 000 USD

Last Quarter

+191 476 000 USD

Current Year

+449 217 000 USD

Last Year

+336 896 000 USD

Current Quarter

+124 221 000 USD

Last Quarter

+116 987 000 USD

Key Figures GH

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -401 207 008 USD
Operating Margin TTM -62.79 %
Price to Earnings
Return On Assets TTM -16.95 %
PEG Ratio
Return On Equity TTM -4 584.47 %
Wall Street Target Price 56.24 USD
Revenue TTM 739 016 000 USD
Book Value -1.13 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY 30.20 %
Dividend Yield
Gross Profit TTM 449 216 992 USD
Earnings per share -3.70 USD
Diluted Eps TTM -3.70 USD
Most Recent Quarter IV 2024
Quarterly Earnings Growth YOY
Profit Margin -59.05 %

Dividend Analytics GH

Max Ratio

>10 - expected double digit dividend yield on cost over 10Y >5 - expected 5-9 dividend yield on cost over 10Y <5 - expected <5 dividend yield on cost over 10Y MaxRatio is an estimated 10Y dividend yield on cost calculated by combining the current dividend yield with the 5-year & 10-year average dividend growth rate, projected over the next 10 years discounted based on current Financial Score. It provides a projected outlook on future dividend returns.

5Y Dividend Growth

Consecutive Years

5Y Average Payout Ratio

Dividend History GH

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Ex Dividend Date
Dividend CAGR 3Y
Dividend CAGR 5Y
Dividend CAGR 10Y
Consecutive Years
Consistent Years
Continuous Dividends
Forward Annual Dividend Yield
Forward Annual Dividend – USD
Last Split Factor
Payout Ratio TTM
Last Split Date

Stock Valuation GH

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue 8.29
Price Sales TTM 7.92
Enterprise Value EBITDA -5.40
Price Book MRQ 55.67

Financials GH

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators GH

For 52 weeks

17.52 USD 50.89 USD
50 Day MA 43.61 USD
Shares Short Prior Month 8 345 886
200 Day MA 33.99 USD
Short Ratio 3.94
Shares Short 8 281 364
Short Percent 6.99 %